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Abstract:
Background: The effects of lead exposure on thyroid function are unclear.
Methods: Serum thyroxine (T4) was evaluated among 137 lead-exposed workers and 83 non-exposed workers. Free thyroxine (FT4) 
was evaluated among a subset of these workers. Exposure metrics included blood lead level (BLL), which reflects recent exposure, 
zinc protoporphyrin (ZPP), a marker of intermediate-duration lead exposure, exposure duration, and estimated cumulative exposure. 
  Multiple linear regression results were adjusted for age, race, and current smoking status.
Results: Mean BLLs were 38.9 µg/dL in lead exposed workers and 2.1 µg/dL in non-exposed workers. The adjusted mean T4 and FT4 
concentrations among exposed and non-exposed workers were similar. While T4 was not significantly related to any of the exposure 
metrics, FT4 was inversely related to the logged values of both exposure duration and cumulative exposure, but not to ZPP or BLL.
Conclusions: The findings suggest that FT4 levels may be related to long-term lead exposure.
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Introduction
Lead is one of the oldest known occupational and 
environmental  poisons,  but  one  whose  properties 
make it a valuable industrial metal. Lead has long 
been  known  to  affect  the  neurological,  renal,  and 
reproductive  systems.1  Scientific  understanding  of 
lead toxicity in other organ systems and at low levels 
of exposure continues to evolve.2
The two primary thyroid hormones are thyroxine 
(T4) and triiodothyronine (T3). T3 and T4 primarily 
circulate bound to carrier proteins; less than 1% of 
each circulates unbound as free T3 (FT3) and free 
T4 (FT4), respectively. The unbound or “free” frac-
tion is responsible for the biological effects. Thyroid 
hormone production is regulated by a complex nega-
tive feedback system controlled by the hypothalamus 
through the pituitary gland, with thyroid stimulating 
hormone (TSH) an important mediator. Thyroid func-
tion is primarily evaluated by serum testing of TSH, 
T4, FT4, T3, and FT3.
Several studies have evaluated the effects of lead 
on thyroid hormone levels. Moline and Landrigan3 
note that thyroid function is often depressed in lead-
exposed workers. However, the findings have been 
inconsistent.  Differences  in  exposure  levels  may 
explain some of the disparity. Decreased thyroid hor-
mone levels have been reported primarily in studies 
of workers with higher exposure levels, with mean   
blood lead levels (BLL) above 60 µg/dL (micrograms 
of  lead  per  deciliter  of  blood);  at  lower  exposure 
levels, results have been mixed, with studies report-
ing increases, decreases, or no change in hormone 
levels.4 Moreover, some studies of highly exposed 
workers observed no association between lead expo-
sure and serum thyroid hormones.5 Potential reasons 
for these disparities include small sample sizes, poten-
tial confounders, and differences in clinical laboratory 
assessments.4 The lack of scientific consensus about 
the effects of lead exposure on thyroid hormone lev-
els demonstrates the need for additional research.
In  1994,  the  National  Institute  for  Occupational 
Safety and Health (NIOSH) performed a cross-sec-
tional study6 comparing immunologic factors in work-
ers occupationally exposed to lead (“exposed”) and 
manufacturing workers without lead exposure (“non-
exposed”). As part of the study, sera from exposed and 
non-exposed participants were analyzed for T4, BLL, 
and zinc protoporphyrin (ZPP). Two years later, FT4 
was analyzed in stored serum from study participants 
who gave consent for serum remaining from the study 
to be used for future research. In order to elucidate 
the relations between occupational lead exposure and 
thyroid hormone levels, the current study compared 
T4 and FT4 levels to several metrics of lead exposure 
among workers with and without occupational lead 
exposure.
Materials and Methods
Study population
In  the  original  study,  lead-exposed  workers  were 
recruited from a large secondary lead smelter (a facil-
ity that recycled batteries) in the southeastern US. 
A non-exposed comparison group was recruited from 
a nearby hardware manufacturing plant that mainly 
produced metal door hinges. Male employees on first 
and second shift who were hired at least six months 
prior to the study were invited to participate. Women 
were not invited to participate because of the small 
number  of  lead-exposed  female  employees  at  the 
secondary lead smelter. Because the study evaluated 
immunologic factors, exclusion criteria were devel-
oped based on factors known or suspected to alter 
immune response. Exclusion criteria (at the time data 
were collected) included use of medications (such as 
corticosteroids) known to alter immune function, or 
serious illnesses of the immune system (such as leu-
kemia or acquired immune deficiency syndrome).
The  original  study  examined  145  lead  exposed 
and  84  non-exposed  workers.  The  study  protocol 
was approved by the Human Subjects Review Board 
of NIOSH. Informed consent was obtained from all 
participants.  Blood  was  obtained  to  measure  BLL 
(which provides an estimate of recent exposure), ZPP 
(which provides an estimate of intermediate duration 
lead exposure), and serum T4. Numerous measure-
ments of immune function were made and have been 
reported previously.6 Many, but not all, participants 
gave consent for any remaining sera to be used for 
future research.
Participants were also administered a questionnaire 
that  included  personal  demographic  information, 
medical history, medication use, smoking and drink-
ing habits, and work history. Self-reported medication 
use was later reviewed for any use of medications that 
affect thyroid   function. Six exposed and two non-
exposed   participants reported aspirin use, but below Thyroid hormones in lead-exposed workers
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the 2600 mg daily dose associated with a potential to 
alter thyroid   function.7 One exposed participant was 
excluded for daily use of phenytoin, reported to alter 
thyroid function.7 No participants reported a history 
of thyroid disease or a hobby (such as bullet casting) 
or previous employment which would entail expo-
sure to lead.
At the time of the original study, not all partici-
pants consented to allow their remaining sera to be 
analyzed for future research and not all stored serum 
samples had sufficient volume remaining for analysis 
of FT4. For the final analysis, there were 137 lead-ex-
posed participants, of whom 83 also had a FT4 result 
available, and 83 non-exposed participants, of whom 
47  also  had  a  FT4  result  available.  One  exposed 
participant had a T4 of 16.2 µg/dL (normal range 
5.0–12.0 µg/dL), 6.2 standard deviations above the 
mean of 5.7 µg/dL, but had no available FT4 result. 
The results presented here omit this participant, giv-
ing final analyses of 136 lead-exposed and 83 non-
exposed workers.
Exposure characterization
The primary exposure at the secondary lead smelter 
was lead. According to company air monitoring data, 
air concentrations of arsenic and other elements were 
negligible. Areas of the hardware manufacturing plant 
where  exposure  to  chemicals  was  negligible  were 
identified based on a review of the Material Safety 
Data Sheets and a walkthrough survey of the plant. 
The non-exposed comparison group was limited to 
workers who were employed in these areas. NIOSH 
investigators also conducted air sampling for metals 
and oil mists at the hardware manufacturing plant; air 
concentrations were negligible.6
Sample collection
In 1994, blood was collected for the original study 
by antecubital venipuncture into trace element tubes 
for blood lead analysis and serum separator tubes 
to isolate sera. The sera were separated on site by 
centrifugation at 1,000 × g for 10 minutes for serum 
chemistry  analyses.  All  tests  were  performed  by 
methods consistent with established guidelines for 
clinical analysis and in compliance with regulations 
of the Clinical Laboratory Improvement Act.8 Extra 
serum remaining from the original study was stored 
at −70 °C.
clinical chemistry
Blood  lead  analyses  and  ZPP  measurements  were 
performed  by  a  commercial  laboratory  (Smith-
Kline  Beecham,  St.  Louis,  MO,  OSHA  certified). 
T4 measurements were performed at NIOSH (Cin-
cinnati, OH) using a centrifugal chemistry analyzer 
(COBAS FARA II, Roche, Inc., Nutley, NJ) using 
reagents and standards supplied by the manufacturer. 
FT4  measurements  were  performed  on  previously 
stored  sera  by  a  commercial  laboratory  (Corning 
Hazelton, Inc., Vienna, VA) using a solid-state  125I 
radioimmunoassay.
Statistical analysis
Participant  demographic  and  biometric  character-
istics,  T4,  and  FT4  of  exposed  and  non-exposed 
participants were compared with t-tests for continu-
ous  variables,  and  Chi-square  tests  for  categorical 
variables.    Similarly,  characteristics  of  participants 
with both T4 and FT4 results available were com-
pared to participants with only T4 results.
Multiple linear regression analyses were used to 
examine the relations between measures of lead expo-
sure and measures of thyroid function (T4 and FT4). 
A dichotomous variable indicating whether the sub-
ject was occupationally exposed to lead was the ini-
tial exposure variable included in the models. These 
models were used to obtain adjusted (“least squares”) 
mean values in the lead-exposed and non-exposed 
groups for T4 and FT4. For all regression models, 
potential confounders and effect modifiers examined 
included age, race, body mass index, smoking (cur-
rent status, pack years), and alcohol use.
In order to evaluate exposure-response relations 
in  the  group  of  lead-exposed  workers,  regression 
analyses were conducted in which the dichotomous 
exposure variable was replaced by a continuous expo-
sure biometric (current BLL or current ZPP) or by 
a continuous non-biological exposure metric (dura-
tion of lead exposure or an estimate of cumulative 
lead  exposure).  Cumulative  lead  exposure  (in  µg/
dL•years) was estimated for the lead-exposed partic-
ipants from historical blood lead monitoring results 
with the equation
B(t)dt (1/2)(B +B )t ii +1
i=1
n-1
=∑ ∫ ∆
0
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where Bi and Bi+1 are the ith and (i + 1)th blood lead 
measurements (in µg/dL), respectively; ∆t is the time   
interval  (in  years)  between  measurements;  and  n 
is  the  total  number  of  blood  lead  measurements. 
Time-integrated blood lead concentration has been 
reported to correlate with measurements of bone lead, 
which is considered a measure of cumulative lead 
exposure.9,10
All analyses were performed using SAS Version 
9.1 (SAS Institute, Cary, NC). Values of blood lead 
below the limit of detection (2 µg/dL) were estimated 
by dividing the limit of detection by two.11
Results
Demographic  information  and  exposure  measure-
ments for lead-exposed and non-exposed participants 
are  shown  in  Tables  1  and  2.  Lead-exposed  par-
ticipants were older, on average, than non-  exposed 
participants ( P = 0.03) and more likely to be African-
American ( P = 0.002). The mean body mass index 
of exposed and non-exposed participants was similar 
( P = 0.57). The mean BLL was 38.9 µg/dL among 
exposed  participants  and  2.1  µg/dL  among  non-
exposed  participants,  while  the  median  ZPP  was 
48.0 µg/dL in exposed workers and 18.0 µg/dLin the 
non-exposed. The median duration of lead exposure 
among  exposed  participants  was  4.8  years  (range: 
0.5–18.4 years). The group of participants with both 
T4  and  FT4  results  and  the  group  of  participants 
with T4 results only were similar in terms of BLL, 
ZPP, T4, and demographic characteristics.
The unadjusted mean T4 levels of lead-exposed 
and non-exposed participants (Table 2) were similar 
( P = 0.25), but the unadjusted mean FT4 was margin-
ally lower among lead-exposed participants than non-
exposed participants ( P = 0.06).
Age was a confounder for all of the regression 
models for FT4, and race and current smoking status 
(current smoker yes/no) were confounders for some 
of the exposure metrics in models for FT4 and T4. 
For consistency, age, race, and current smoking status 
were included in all of the final models. All models 
Table 1. characteristics of workers exposed to lead at a 
secondary lead smelter and non-exposed workers.†
exposed 
n = 136‡
non-
exposed 
n = 83
Mean age (yrs)* 32.9 (8.5) 30.2 (9.3)
Mean body mass index  
(kg/m2)
27.8 (5.4) 27.3 (5.5)
race*
  caucasian 54 (39.7%) 51 (61.4%)
  African-American 82 (60.3%) 32 (38.6%)
Smoking status
  never smoker 70 (51.5%) 34 (41.0%)
  Former smoker 19 (14.0%) 14 (16.9%)
  current smoker 47 (34.6%) 35 (42.2%)
Mean pack years of smoking 4.8 (9.6) 4.0 (7.5)
Alcohol use (1 drink/wk, 
on average, during last 
6 months)
84 (61.8%) 46 (55.4%)
notes: †results are presented as mean (standard deviation) or number 
(%);  ‡A few individual data items were missing for some participants. 
The  total  number  of  exposed  and  non-exposed  participants  used  in 
these analyses ranged from 135 to 136 and from 82 to 83, respectively, 
because of missing data. *P , 0.05.
Table 2. Exposure metric levels and selected thyroid hormone levels for workers exposed to lead at a secondary lead 
smelter and non-exposed workers.†
exposed 
n = 136‡
non-exposed 
n = 83
Differences 
P-value
Mean blood lead level (µg/dL) 38.9 (8.7) 2.1 (1.8) ,0.0001
Median zinc protoporphyrin (µg/dL) 48.0 (2–424) 18.0 (1–59) ,0.0001
Median time-weighted average blood lead level  
over years of lead exposure (µg/dL)
36.5 (14.2–55.8) not applicable
Median duration of lead exposure (years) 4.8 (0.5–18.4) not applicable
Median estimated cumulative lead exposure  
(µg/dL•year)
151.6 (7.6–969.2) not applicable
Mean T4 (µg/dL) 5.81 (1.34) 6.01 (1.04) 0.25
Mean FT4 (ng/dL) 1.10 (0.26) 1.18 (0.23) 0.06
notes: †results are presented as mean (standard deviation) or median (range); ‡A few individual data items were missing for some participants. The total 
number of exposed and non-exposed participants used in these analyses ranged from 135 to 136 and from 82 to 83, respectively, because of missing data.
136 exposed and 83 non-exposed workers were included in the analyses of T4. 83 exposed and 47 non-exposed workers were included in the analyses 
of FT4.Thyroid hormones in lead-exposed workers
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satisfied the usual assumptions of independent nor-
mally distributed errors with equal variance.
In  regression  analyses  conducted  for  exposed 
workers, the logged values of ZPP, exposure duration, 
and estimated cumulative exposure were used, due to 
the skewed distributions of these variables. BLL was 
approximately normally distributed, so the unlogged 
values were used for BLL.
After adjusting for age, race, and current smok-
ing status, exposed and non-exposed participants had 
similar mean levels of T4 (exposed = 5.86 µg/dL, 
non-exposed  =  5.92  µg/dL,  P  .  0.74)  and  FT4 
(exposed = 1.11 µg/dL, non-exposed = 1.16 µg/dL, 
P = 0.26). In analyses adjusted for age, race, and 
current smoking, T4 did not show a statistically sig-
nificant  relation  with  any  of  the  exposure  metrics 
(Table 3). In contrast, FT4 was inversely related to the 
logged values of both exposure duration (P = 0.04) 
and cumulative exposure (P = 0.05), but not to either 
of the biological exposure metrics. R2   values for the 
models were low, but were higher for the models 
of FT4.
Discussion and conclusions
This study found no difference in mean T4 or FT4 
between  exposed  and  non-exposed  workers  after 
adjusting for age, race, and current smoking status. 
While  the  concentration  of  T4  was  not  associated 
with any exposure metric in models adjusted for age, 
race, and current smoking status, the serum concen-
tration of FT4 was negatively associated with both 
exposure duration and cumulative exposure. The rea-
sons for this are unknown. Other investigators have 
found that lead decreases thyroid uptake of iodine12 
and may adversely affect the pituitary-thyroid axis.13,14 
Our findings suggest that lead may affect the equilib-
rium between protein-bound and free hormone. Free 
thyroid hormones represent less than 1% of all thyroid 
hormones but are responsible for biological effects.15 
A process that alters protein binding could disrupt bio-
logical effects by dramatically altering the amount of 
free thyroid hormones while maintaining normal or 
near normal levels of total T4 and TSH. Although FT4 
results were available only for a subset of participants 
in this study, the groups of participants with and with-
out FT4 results available were similar with respect to 
demographic characteristics, body mass index, smok-
ing, and exposure metrics, suggesting that differences 
in the findings are not due to bias in the sample.
Previous research on the effects of lead on thyroid 
function has had widely varying results. A number of 
studies have examined the relation between thyroid hor-
mone levels and BLL, which reflects recent lead expo-
sure. Some studies have suggested that BLLs higher 
than  those  in  the  current  study  are  associated  with 
decrements in thyroid hormone levels.13,14,16   However, 
similar  findings  have  not  generally  been  observed 
in studies of workers with BLLs less than 60 µg/dL. 
Refowitz17  and  Schumacher  and  colleagues18  found 
no association with BLL and thyroid hormone levels 
among groups of workers with mean BLLs less than 
∼60  µg/dL.  In  contrast,  Gustafson  and  colleagues19 
and Dursun and Tutus20 found higher levels of T4, on 
average, among exposed workers with mean BLLs of 
39.4 µg/dL and 17.07 µg/dL, respectively, than among 
non-exposed workers. Dursun and Tutus20 also found 
higher  levels  of  FT4  and  FT3,  on  average,  among 
exposed workers. Singh et al21 found no difference in 
T3 and T4 between controls and a group of exposed 
workers with a mean BLL of 51.9; however, mean TSH 
Table 3. Association of measures of lead exposure with the level of thyroxine (T4) and free thyroxine (FT4)†.
T4 FT4
Coefficient P-value Coefficient P-value
Occupational lead exposure (Yes = 1) −0.05758 0.74 −0.05172 0.26
Blood lead level (µg/dL)‡ −0.00977 0.46 −0.00173 0.65
natural log (zinc protoporphyrin in µg/dL)‡ −0.20430 0.16 −0.05186 0.20
natural log (duration of exposure in years)‡ −0.14911 0.27 −0.06933 0.04
natural log (estimated cumulative lead  
exposure in µg/dL•year)‡
−0.17595 0.13 −0.05805 0.05
notes: †All multiple linear regression models included age, race, current smoking status, and an exposure variable (occupational lead exposure, blood 
lead level, or the natural log of zinc protoporphyrin, duration of exposure, or estimated cumulative lead exposure); ‡The last eight models were restricted 
to exposed workers.Bledsoe et al
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was significantly higher in the exposed group. Lopez 
and colleagues16 found a positive correlation between 
BLL and T3, T4, FT4, and TSH at BLLs below 50 µg/
dL and a negative correlation between BLL and T3, 
T4, and FT4 at BLLs above 50 µg/dL, suggesting the 
existence of a threshold effect. In the current study of 
workers with current BLLs below 60 µg/dL, no asso-
ciation was observed between T4 or FT4 and occupa-
tional lead exposure (yes/no) or BLL.
Relatively  few  studies  have  evaluated  the  effect 
of  chronic  or  cumulative  lead  exposure  on  thyroid 
function; most have used duration of exposure as a 
surrogate of chronic lead exposure. Tuppurainen and 
colleagues22  found  negative  correlations  between 
duration of exposure and both T4 and FT4, especially 
among workers with individual average BLLs above 
56.6 µg/dL, suggesting that chronic, intense lead expo-
sure may depress thyroid function. Dursun and Tutus20 
found  a  negative  association  between  duration  of 
exposure and T4 but not FT4. In contrast, Gennart and 
colleagues23 found no relationship between duration of 
exposure and T3, T4, FT4 index, or TSH. Erfurth and 
colleagues24 found no relationship for FT4, FT3, and 
TSH with two metrics designed to estimate long-term 
exposure: a cumulative blood lead index and finger 
bone lead. The current study found negative associa-
tions between concentrations of FT4, but not T4, and 
long-term exposure (as measured by either exposure 
duration or estimated cumulative lead exposure).
The disparity in findings among studies of lead 
exposure and thyroid function may be related to study 
limitations such as sample size, or to non-comparabil-
ity between studies. Other limitations include absence 
of a non-exposed referent group,13,14,17,18,22 relatively 
high BLLs in the “non-exposed” referent group,23,16 
and lack of data on potential confounders such as age, 
race, alcohol use, and/or smoking.13,16–24 For studies 
examining the effects of exposure duration, dispari-
ties in the results may be related to between-study dif-
ferences in the relations between exposure duration 
and cumulative lead exposure.
The current study has several limitations. T4 and FT4 
were evaluated, but TSH, T3, and FT3   measurements 
were not available. In addition, FT4 could be evalu-
ated only for a subset of participants. A more compre-
hensive laboratory battery would have been desirable. 
As with any cross-sectional study, it is impossible to 
detect temporal associations between exposure and 
outcome  variables;  moreover,  numerous  associa-
tions were evaluated, and some of the findings may 
have attained statistical significance by chance. The 
R2 values for the relations between blood lead levels 
and thyroid hormones were low in this study, as in 
other studies of this topic. This suggests that other 
factors not taken into account by these studies, such 
as  genetic  polymorphisms25  may  have  substantial 
explanatory value. Another limitation is that informa-
tion on potential confounders was from self reports; 
there was no validation of reports of personal habits, 
medical history or medication use.
Strengths of the study include having participants 
with significant lead exposure but BLLs allowable under 
the current lead standard (29 CFR Part 1910.1025)26 
and a large number of participants in exposed as well 
as non-exposed groups. Some previous studies reported 
relatively  high  BLLs  for  non-exposed  comparison 
groups, suggesting that those participants had signifi-
cant environmental lead exposure from some source, 
whether occupational or not. The low mean BLL for 
non-exposed participants in this study suggests that non-
exposed participants had little recent lead exposure.
Another strength of this study is the use of mul-
tiple measurements of lead exposure. The complexity 
of lead metabolism limits the value of a single vari-
able in estimating the biological burden on people 
chronically exposed.27 This study used multiple vari-
ables to seek insight into whether short, medium, or 
long-term exposure is potentially most damaging to 
thyroid metabolism. BLL provides the best measure-
ment for recent lead exposure. ZPP reflects interme-
diate lead exposure over the previous three to four 
months.27  Duration  of  exposure  and  estimates  of 
cumulative lead exposure (the calculation of which 
is described above) provided two different but related 
ways of considering long-term lead exposure.
In summary, the findings suggest that the concen-
tration of FT4 may be inversely related to long-term 
lead exposure. In contrast, T4 was not associated with 
metrics of lead exposure (BLL, ZPP, exposure dura-
tion, or estimated cumulative exposure).
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